Barclays Rates Keurig Dr Pepper (KDP) buy, $36 Price Target
Barclays analyst Lauren Lieberman issued a 'buy' rating for Keurig Dr Pepper, raising the price target to $36, a 7.78% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Barclays rated Keurig Dr Pepper Inc. ($KDP) "buy" with a $36 price target on June 25, 2026.
Since the rating, $KDP is up 3.1% after 1 week, down 6.7% after 1 month and up 8.0% to date (from the $32.06 close on Jun 25, 2026).
KDP
Keurig Dr Pepper Inc.
Key Points
- Barclays raised its rating on Keurig Dr Pepper to 'buy' with a $36 target on June 25, 2026.
- Barclays's $36 price target implies 7.78% upside from Keurig Dr Pepper Inc.'s ($KDP) current $33.40 share price.
- Shares of NasdaqGS:KDP traded near $31.40 on Thursday, with a market cap of $42 billion and a P/E ratio of 22.87.
- Recent insider activity includes sales by CEO Timothy Cofer and Senior VP Angela Stephens, while FMR LLC and BlackRock increased their holdings.
Get $KDP trade alerts by text
We text you when insiders, Congress or big funds trade $KDP. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Keurig Dr Pepper Inc. alert may contain errors. Disclosures
On June 25, 2026, Barclays analyst Lauren Lieberman upgraded Keurig Dr Pepper Inc. (NasdaqGS:KDP) to a 'buy' rating, setting a new price target of $36. This change comes as Keurig Dr Pepper's shares traded near $31.40 on Thursday.
Barclays vs. the S&P 500
Hypothetical returns from Barclays's disclosed trades, not real profit or advice. How we model this.
Keurig Dr Pepper Inc. Stock Up 7.9%
Shares of Keurig Dr Pepper traded around $31.40 on Thursday. The company, with a market cap of about $42 billion, has a P/E ratio of 22.87 and a forward P/E of 12.23. Its stock has experienced a 52-week low of $24.88 and a high of $35.94, while maintaining a 50-day moving average of $29.05 and a 200-day moving average of $27.95. The company's beta is 0.424, indicating lower volatility compared to the market.
$KDP price target
Keurig Dr Pepper Inc. daily closes and this analyst's $36 target. Not advice.
Insider Buying and Selling at Keurig Dr Pepper Inc.
Recent insider activity at Keurig Dr Pepper includes several transactions by CEO Timothy Cofer and Senior VP & Controller Angela Stephens. On May 20, 2026, Timothy Cofer sold 34,670 shares at an average price of $28.69. Angela Stephens executed multiple transactions on June 1, 2026, buying and selling shares, with a notable sale of 1,161 shares at $30.20.
Analysts Set New Price Targets
On June 25, 2026, Barclays upgraded its rating of Keurig Dr Pepper to 'buy' and set a price target of $36. Earlier, on June 12, 2026, Bernstein initiated coverage on the company with a 'buy' rating and a $38 target. The consensus recommendation for Keurig Dr Pepper is 'buy', with an average target price of $33.53 based on 17 analyst opinions.
About Keurig Dr Pepper
Keurig Dr Pepper Inc. is a major beverage company headquartered in Frisco, Texas. It owns, manufactures, and distributes a wide range of beverages and single-serve brewing systems across the United States and internationally. The company operates through segments focused on refreshment beverages, coffee, and international markets. Its product lineup includes popular brands like Dr Pepper, Canada Dry, Snapple, and Green Mountain Coffee Roasters. Led by CEO Timothy P. Cofer, Keurig Dr Pepper employs approximately 30,600 people.
Bottom Line
Barclays' upgrade to a 'buy' rating with a $36 target reflects increased confidence in Keurig Dr Pepper. Investors often track such upgrades as they can signal potential future performance. Keep in mind, analyst ratings and targets are based on current assessments and could change. Always consider these insights as part of a broader investment strategy.
Related Filing Alerts
Source: Barclays's rating change on $KDP (Jun 25, 2026). Written by software, not financial advice. How we make alerts